{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:34:41Z","timestamp":1793392481766,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T00:00:00Z","timestamp":1661644800000},"content-version":"am","delay-in-days":392,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.nmd.2021.06.004","type":"journal-article","created":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T07:02:38Z","timestamp":1623481358000},"page":"756-764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Leukoencephalopathy and conduction blocks in PLEKHG5-associated intermediate CMT disease"],"prefix":"10.1016","volume":"31","author":[{"given":"Rocio-Nur","family":"Villar-Quiles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Van Thuy","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Leonard-Louis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Thi","family":"Trang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Thi","family":"Huong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilia","family":"Laddada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Francou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Maisonobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Azzedine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Stojkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2021.06.004_bib0001","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/WCO.0000000000000735","article-title":"Charcot-marie-Tooth disease and related disorders: an evolving landscape","volume":"32","author":"Laur\u00e1","year":"2019","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.nmd.2021.06.004_bib0002","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/jnnp-2012-302451","article-title":"Charcot-marie-tooth disease: frequency of genetic subtypes and guidelines for genetic testing","volume":"83","author":"Murphy","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2021.06.004_bib0003","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1086\/518900","article-title":"The nuclear factor \u03baB-activator gene PLEKHG5 is mutated in a form of autosomal recessive lower motor neuron disease with childhood onset","volume":"81","author":"Maystadt","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nmd.2021.06.004_bib0004","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1093\/hmg\/ddt274","article-title":"pLEKHG5 deficiency leads to an intermediate form of autosomal-recessive charcot-marie-tooth disease","volume":"22","author":"Azzedine","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2021.06.004_bib0005","article-title":"Mutations in the PLEKHG5 gene is relevant with autosomal recessive intermediate charcot-marie-tooth disease","volume":"8","author":"Kim","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nmd.2021.06.004_bib0006","article-title":"Novel variants broaden the phenotypic spectrum of PLEKHG5-associated neuropathies","author":"Chen","year":"2020","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2021.06.004_bib0007","article-title":"Novel PLEKHG5 mutations in a patient with childhood-onset lower motor neuron disease","author":"Gonzalez-Quereda","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.nmd.2021.06.004_bib0008","doi-asserted-by":"crossref","first-page":"1764.e9","DOI":"10.1016\/j.neurobiolaging.2014.12.032","article-title":"The distinct genetic pattern of ALS in Turkey and novel mutations","volume":"36","author":"\u00d6zo\u011fuz","year":"2015","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.nmd.2021.06.004_bib0009","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cnp.2019.10.005","article-title":"Fuglsang-frederiksen a. evidence-based recommendations for examination and diagnostic strategies of polyneuropathy electrodiagnosis","volume":"4","author":"Tankisi","year":"2019","journal-title":"Clin Neurophysiol Pract"},{"key":"10.1016\/j.nmd.2021.06.004_bib0010","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","volume":"17","author":"Van Den Bergh","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2021.06.004_bib0011","series-title":"Muscle biopsy: a practical approach","author":"Dubowitz","year":"2007"},{"key":"10.1016\/j.nmd.2021.06.004_bib0012","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/s41582-019-0254-5","article-title":"Next-generation sequencing in Charcot-marie-tooth disease: opportunities and challenges","volume":"15","author":"Pipis","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.nmd.2021.06.004_bib0013","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4103\/0972-2327.53075","article-title":"Classification and diagnosis of the inherited neuropathies","volume":"12","author":"Reilly","year":"2009","journal-title":"Ann Indian Acad Neurol"},{"key":"10.1016\/j.nmd.2021.06.004_bib0014","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2019-320717","article-title":"Expanding the spectrum of genes responsible for hereditary motor neuropathies","volume":"90","author":"Previtali","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2021.06.004_bib0015","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ng.2653","article-title":"The genotype-tissue expression (GTEx) project","volume":"45","author":"Lonsdale","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.nmd.2021.06.004_bib0016","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-00689-z","article-title":"Plekhg5-regulated autophagy of synaptic vesicles reveals a pathogenic mechanism in motoneuron disease","volume":"8","author":"L\u00fcningschr\u00f6r","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.nmd.2021.06.004_bib0017","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0960-9822(02)00658-9","article-title":"The human Rho-GEF Trio and its target GTPase RhoG are involved in the NGF pathway, leading to neurite outgrowth","volume":"12","author":"Estrach","year":"2002","journal-title":"Curr Biol"},{"key":"10.1016\/j.nmd.2021.06.004_bib0018","doi-asserted-by":"crossref","first-page":"6980","DOI":"10.1523\/JNEUROSCI.22-16-06980.2002","article-title":"Kalirin Dbl-homology guanine nucleotide exchange factor 1 domain initiates new axon outgrowths via RhoG-mediated mechanisms","volume":"22","author":"May","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.nmd.2021.06.004_bib0019","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.00185","article-title":"Absence of Plekhg5 results in myelin infoldings corresponding to an impaired schwann cell autophagy, and a reduced T-Cell infiltration into peripheral nerves","volume":"14","author":"L\u00fcningschr\u00f6r","year":"2020","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.nmd.2021.06.004_bib0020","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1529-8027.2012.00382.x","article-title":"Characteristics of clinical and electrophysiological pattern of charcot-marie-tooth 4C","volume":"17","author":"Yger","year":"2012","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.nmd.2021.06.004_bib0021","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.nmd.2013.01.010","article-title":"Rapidly progressive asymmetrical weakness in charcot-marie-tooth disease type 4J resembles chronic inflammatory demyelinating polyneuropathy","volume":"23","author":"Cottenie","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2021.06.004_bib0022","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1212\/WNL.94.15_supplement.230","article-title":"Conduction block in charcot-marie tooth neuropathy type 4J (230)","volume":"94","author":"Li","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2021.06.004_bib0023","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nmd.2010.12.010","article-title":"Conduction block and tonic pupils in charcot-marie-tooth disease caused by a myelin protein zero p.Ile112Thr mutation","volume":"21","author":"Murphy","year":"2011","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2021.06.004_bib0024","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jns.2014.05.029","article-title":"A novel LITAF\/SIMPLE mutation within a family with a demyelinating form of charcot-marie-tooth disease","volume":"343","author":"Ciotti","year":"2014","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nmd.2021.06.004_bib0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1385\/NMM:8:1-2:3","article-title":"Clinical and electrophysiological aspects of charcot-marie-tooth disease","volume":"8","author":"Pareyson","year":"2006","journal-title":"NeuroMolecular Med"},{"key":"10.1016\/j.nmd.2021.06.004_bib0026","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/cge.13881","article-title":"Genetic spectrum of charcot-marie-tooth disease associated with myelin protein zero gene variants in Japan","volume":"99","author":"Taniguchi","year":"2021","journal-title":"Clin Genet"},{"key":"10.1016\/j.nmd.2021.06.004_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.613599","article-title":"Elevated creatinine kinase in peripheral neuropathy is associated with muscle cramping","volume":"12","author":"Jordan","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.nmd.2021.06.004_bib0028","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/brain\/awg012","article-title":"Demyelinating and axonal features of charcot-marie-tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients","volume":"126","author":"Hattori","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2021.06.004_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.00123","article-title":"LAMA2-related dystrophies: clinical phenotypes, disease biomarkers, and clinical trial readiness","volume":"13","author":"Sarkozy","year":"2020","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.nmd.2021.06.004_bib0030","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1055\/s-2007-979777","article-title":"Deficiency of merosin (laminin M or \u03b12) in congenital muscular dystrophy associated with cerebral white matter alterations","volume":"26","author":"Vainzof","year":"1995","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.nmd.2021.06.004_bib0031","first-page":"1611","article-title":"Lysosomal leukodystrophies. krabbe disease and metachromatic leukodystrophy","volume":"113","author":"Kohlsch\u00fctter","year":"2013","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.nmd.2021.06.004_bib0032","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4103\/jpn.JPN_155_18","article-title":"Electroneurography and advanced neuroimaging profile in pediatric-onset metachromatic leukodystrophy","volume":"14","author":"Raina","year":"2019","journal-title":"J Pediatr Neurosci"},{"key":"10.1016\/j.nmd.2021.06.004_bib0033","first-page":"1","article-title":"Central nervous system demyelination in a charcot-marie-tooth type 1A patient","volume":"2013","author":"Koros","year":"2013","journal-title":"Case Rep Neurol Med"},{"key":"10.1016\/j.nmd.2021.06.004_bib0034","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/ana.10305","article-title":"Transient central nervous system white matter abnormality in X-linked charcot-marie-tooth disease","volume":"52","author":"Paulson","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2021.06.004_bib0035","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00415-008-0847-1","article-title":"Cerebral involvement in axonal charcot-marie-tooth neuropathy caused by mitofusin2 mutations","volume":"255","author":"Brockmann","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2021.06.004_bib0036","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00415-015-7985-z","article-title":"NEFL N98S mutation: another cause of dominant intermediate charcot-marie-tooth disease with heterogeneous early-onset phenotype","volume":"263","author":"Berciano","year":"2016","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2021.06.004_bib0037","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ana.24824","article-title":"Cerebral white matter abnormalities in patients with charcot-marie-tooth disease","volume":"81","author":"Lee","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2021.06.004_bib0038","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1007\/s10147-019-01503-0","article-title":"PLEKHG5 is a novel prognostic biomarker in glioma patients","volume":"24","author":"Qian","year":"2019","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.nmd.2021.06.004_bib0039","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1560","article-title":"How to get away with nonsense: mechanisms and consequences of escape from nonsense-mediated RNA decay","volume":"11","author":"Dyle","year":"2020","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"10.1016\/j.nmd.2021.06.004_bib0040","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0968-0004(98)01208-0","article-title":"A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance","volume":"23","author":"Nagy","year":"1998","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.nmd.2021.06.004_bib0041","first-page":"1098","article-title":"Selective translational repression of truncated proteins from frameshift mutation-derived mRNAs in tumors","volume":"5","author":"Kwon","year":"2007","journal-title":"PLoS Biol"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896621001589?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896621001589?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:07:33Z","timestamp":1793390853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896621001589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0960896621001589"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2021.06.004","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leukoencephalopathy and conduction blocks in PLEKHG5-associated intermediate CMT disease","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2021.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}